TETRACYCLINE COMPLEXES WITH SUSTAINABLE ACTIVITY Russian patent published in 2023 - IPC C07C237/24 C07C237/26 A61K9/00 A61K9/14 A61K31/65 A61K47/34 A61P31/04 

Abstract RU 2806036 C2

FIELD: pharmaceuticals.

SUBSTANCE: complex formed from a tetracycline compound (TC) or a pharmaceutically acceptable salt, hydrate or solvate thereof and a divalent metal carboxylate (MA2), in which the TC:MA2 molar ratio is in the range of 1:0.8-3.0, the divalent metal cation M is an alkaline earth metal cation and A is a carboxylate anion derived from a C8-C24 carboxylic acid. The tetracycline (TC) compound is selected from minocycline, doxycycline, chlortetracycline, rolitetracycline, tigecycline, demeclocycline, lymecycline, meclocycline, metacycline, omadacycline, sarecycline, eravacycline, clomocycline, 9-(N,N-dimethylglycilamido)-6-demethyl-6 -deoxytetracycline and 9-(N,N-dimethylglycylamido)minocycline. The invention also relates to a pharmaceutical preparation, methods for obtaining the specified complex and pharmaceutical preparation, the use of the specified complex and a method for treatment using the specified complex or pharmaceutical preparation. The tetracycline compound complexes of the present invention degrade more slowly in aqueous media than the corresponding tetracycline compounds and have lower solubility in water and provide a more delayed and sustained release than the corresponding tetracycline compounds.

EFFECT: proposed complexes can be used for the treatment and/or prevention of bacterial infection or acute, chronic or recurrent periodontal disease.

20 cl, 23 dwg, 4 tbl, 18 ex

Similar patents RU2806036C2

Title Year Author Number
METHOD OF PRODUCING POWDER CONTAINING PROTEIN WHICH IS HUMAN BLOOD COAGULATION FACTOR AND LACTIC ACID-BASED POLYMER 2016
  • Tome Alcalde, Juan
  • Windhab, Norbert
  • Liefke, Melanie
  • Benedikt, Anne
  • Muller-Albers, Jessica
  • Tice, Tom
  • Ullrich, Susanne
  • Engel, Andrea
  • Germer, Matthias
  • Kistner, Steffen
  • Daufenbach, Jens
RU2702740C2
DEGRADABLE REMOVABLE IMPLANT FOR CONTINUOUS RELEASE OF ACTIVE COMPOUND 2010
  • Shakhter Debora M.
  • Bart Liven Elvire Kolett
  • Kraus Gyunter
  • Chzhan Tsyan
  • Chun Iksu
RU2593790C2
METHOD AND DEVICE FOR PRODUCTION OF SOLID DISPERSION 2018
  • Adage, Tiziana
RU2785565C2
PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) 2009
  • Khol'Ger Peterzen
  • Markus Al'Khajm
RU2541104C2
HIGH STABILITY PHARMACEUTICAL COMPOSITIONS 2007
  • Li Jukhua
  • Chien Bendzhamin
RU2427383C2
PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE 2017
  • Li, Yukhua
  • Guarino, Endryu
RU2756514C1
COMPOSITIONS OF PROLONGEDACTION WITH CONTROLLED RELEASE 2003
  • Chen Guokhua
  • Kh'Juston Pol
  • Bannister Roj
  • Kameda Tereza
  • Prebe Dehvid
  • Klejner Lotar
RU2355385C2
DOSED FORMS OF ANESTHETICS FOR ANESTHESIA WITH LONG LIBERATION 2003
  • Chehn' Gokhua
  • Prebe Dehvid
  • Bannister Roj
  • Kh'Juston Pol
  • Klejner Lotar
RU2332985C2
IMPLANTED DEVICES WITH VARIOUS VERSIONS OF BIOLOGICALLY ACTIVE INGREDIENT LOADING 2010
  • Biggs Dehniell'
RU2545865C2
DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS 2005
  • Jukhua Li
  • Chien Bendzhamin
RU2390355C2

RU 2 806 036 C2

Authors

Kiesow, Andreas

Buchholz, Mirko

Sarembe, Sandra

Maeder, Karsten

Kirchberg, Martin

Eick, Sigrun

Dates

2023-10-25Published

2019-10-29Filed